James S P, Stromeyer F W, Stowens D W, Barranger J A
Prog Clin Biol Res. 1982;95:131-42.
Twenty-five patients with enzymatically confirmed Gaucher disease were selected for study of hepatic complications of the disorder. Hepatomegaly was noted clinically and confirmed by radioisotopic scan in all but 1 patient. The majority had abnormalities of serum transaminase, alkaline phosphatase, and sulfobromophthalein (BSP) clearance. Three patients had evidence of portal hypertension. Light microscopic examination of liver showed some variation in the pattern of the disease. Gaucher cells were present in all specimens. In 5 patients the distribution was in scattered foci throughout the liver lobule. In 14 patients there was prominent centrilobular accumulation of Gaucher cells. Extensive replacement of liver by storage cells and cirrhosis was documented in 3 patients. No patient was found to have amyloid deposits. The severity of hepatic involvement correlated with the occurrence of other severe complications of the disorder. The wide range of liver abnormalities in Gaucher disease should be considered in evaluating patients for participation in experimental therapeutic trials.
选择25例经酶学确诊的戈谢病患者,以研究该疾病的肝脏并发症。除1例患者外,所有患者临床上均有肝肿大,且经放射性同位素扫描证实。大多数患者血清转氨酶、碱性磷酸酶及磺溴酞钠(BSP)清除率异常。3例患者有门静脉高压的证据。肝脏的光镜检查显示该病的模式存在一些差异。所有标本中均存在戈谢细胞。5例患者的戈谢细胞分布于整个肝小叶的散在病灶中。14例患者的戈谢细胞在小叶中央明显聚集。3例患者有贮积细胞广泛替代肝脏及肝硬化的记录。未发现患者有淀粉样沉积。肝脏受累的严重程度与该疾病其他严重并发症的发生相关。在评估患者参与实验性治疗试验时,应考虑戈谢病肝脏异常的广泛范围。